16.05.2013
- Sweden's Recipharm has hired UBS to advise on either a partial sale of the pharmaceutical company or a listing on the Stockholm exchange, a source close to the process told Reuters...
27.03.2013
- Recipharm's solid dose facility located in Fontaine, France, has been approved for supply of manufactured products to the Japan's pharmaceuticals market following a recent...
05.02.2013
- Recipharm Pharmaceutical Development is pleased to announce the appointment of Dr Hans Lennernäs to the company's Board of Directors. Dr. Hans Lennernäs is a Professor of...
23.10.2012
- Recipharm and Astimex Pharma have today announced the formation of a collaboration agreement for the development and manufacture of a pharmaceutical product. The formulation...
